Simpler Grants.gov #HT942526OCRPCTA

Army Solicitation for Ovarian Cancer Research and Clinical Trial Awards

The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA) and the Congressionally Directed Medical Research Programs (CDMRP) Ovarian Cancer Research Program (OCRP), is soliciting research proposals to advance ovarian cancer research and clinical trials. - Government Buyer: - Department of the Army, US Army Medical Research Acquisition Activity (USAMRAA) - Congressionally Directed Medical Research Programs (CDMRP), Ovarian Cancer Research Program (OCRP) - Award Mechanisms: - Clinical Trial Award: Supports rapid implementation of clinical trials for ovarian cancer, including early-phase or pilot trials - Investigator-Initiated Research Award: Funds high-impact research (excluding clinical trials) - Ovarian Cancer Academy Early-Career Investigator Award: Mentoring and collaboration for early-career investigators (no clinical trials) - Ovarian Cancer Clinical Trial Academy Early Career Investigator Award: Supports early-career investigators conducting clinical trials with mentoring - Pilot Award: Funds innovative, high-risk/high-reward research to develop preliminary data (no clinical trials) - Products/Services Requested: - Clinical trial services and research for ovarian cancer, including evaluation of new drugs, biologics, devices, clinical guidance, and emerging technologies - No specific OEMs, products, or part numbers are named; focus is on research and clinical trial services - Funding and Performance: - Funding ranges from $350,000 (Pilot Award) to $2.8 million (Clinical Trial Award) - Periods of performance range from 2 to 4 years depending on award type - Up to two Clinical Trial Awards expected, each capped at $2.8 million - Unique/Notable Requirements: - Open to a wide range of applicants: extramural/intramural, for-profit/nonprofit, domestic/foreign - Some awards require preliminary data, preproposal or letter of intent, and designated mentors for early-career awards - Focus on projects with potential for significant impact on ovarian cancer treatment or management

Description

The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Clinical trials may evaluate new products, pharmacologic agents, devices, clinical guidance, or emerging technologies. Projects can range from small proof-of-concept trials to large-scale trials determining efficacy in relevant patient populations. The program expects to fund approximately two awards with a total funding of $5.6 million and a maximum cost cap of $2.8 million per award over a period of up to 4 years.

View original listing